Ionis Pharma (IONS) Tops Q1 EPS by 3c

Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $144.4 million versus the consensus estimate of $144.01 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
• MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
• Schlumberger (SLB) earnings in-line, revenue beats expectations